 SAN DIEGO, Calif., SUZHOU and SHANGHAI, China, May 19, 2022 PRNewswire -- Gracell Biotechnologies Inc. NASDAQ: GRCL Gracell, a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that the management team will participate in and attend one-on-one meetings at three investor conferences in June 2022 as follows: BTIG China Biotech Day Virtual Fireside chat: June One-on-one meetings: June 1 To listen to the live event, please contact your BTIG representative. 